COMPARATIVE STUDY
JOURNAL ARTICLE
VALIDATION STUDY
Add like
Add dislike
Add to saved papers

Clinical validation of the multiplier method for predicting limb length discrepancy and outcome of epiphysiodesis, part II.

To validate the accuracy of the multiplier method in predicting limb length discrepancy (LLD) and outcome of epiphysiodesis, radiographs of 60 patients treated for LLD were measured. Data generated were used to predict maturity lengths of epiphysiodesed limbs, bone length discrepancies at maturity, and LLD at maturity after epiphysiodesis (residual discrepancy) using the multiplier and Moseley methods. The multiplier method mean error for bone length discrepancies predictions was 0.6 cm (SD = 0.6). Mean error for predicting lengths of epiphysiodesed limbs was 1.6 cm (SD = 1.2) for both methods. Mean errors for predicting residual discrepancies were 0.9 cm for the multiplier method using chronologic age, 1 cm for the multiplier method using skeletal age, and 1.3 cm for the Moseley method. Mean error difference between the methods was significant (P = 0.0008). The multiplier method accurately predicts LLD and outcome of epiphysiodesis and is more accurate than the Moseley method in predicting LLD at maturity after epiphysiodesis.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app